policy
The Admission Office of KAIST has been recruiting prospective international students, and as part of their efforts, they have been visiting such regions as the Americas, Eastern Europe, Central Asia, and Africa. In 2014, the office focused on nations in Africa, visiting Ethiopia, Kenya, Rwanda, and Tanzania.
The visiting KAIST representatives, consisting of faculty, international students, and staff members, hosted an admission conference for high school students in those four nations, offering information on KAIST education and research, as well as introducing Korea.
As a result, a total of 37 African students (5 undergraduate and 32 graduate students) were admitted to KAIST for the 2014 fall semester. Among them was Gemechu Bekele Tolossa (picture below) from Ethiopia, who received the highest score at the Ethiopian college entrance examination in 2013. Tolossa had enrolled in a medical school at Addis Ababa University, Ethiopia, and was at the top of his class, but he left the school in order to apply for KAIST.
When asked about his plan, Tolossa said, “I would like to study engineering and brain science at KAIST. KAIST offers me an excellent environment for learning and research, and I would like to make the most of it.”
KAIST accepted 206 international students this year (45 undergraduate and 161 graduate students), brining the number of international students at 540, approximately 5% of the students enrolled at the university.
-
research Revolutionary 'scLENS' Unveiled to Decode Complex Single-Cell Genomic Data
Unlocking biological information from complex single-cell genomic data has just become easier and more precise, thanks to the innovative 'scLENS' tool developed by the Biomedical Mathematics Group within the IBS Center for Mathematical and Computational Sciences led by Chief Investigator Jae Kyoung Kim, who is also a professor at KAIST. This new finding represents a significant leap forward in the field of single-cell transcriptomics. Single-cell genomic analysis is an advanced technique that m
2024-05-09 -
research KAIST Develops Sodium Battery Capable of Rapid Charging in Just a Few Seconds
Sodium (Na), which is over 500 times more abundant than lithium (Li), has recently garnered significant attention for its potential in sodium-ion battery technologies. However, existing sodium-ion batteries face fundamental limitations, including lower power output, constrained storage properties, and longer charging times, necessitating the development of next-generation energy storage materials. On the 11th of April, KAIST (represented by President Kwang Hyung Lee) announced that a research t
2024-04-18 -
research KAIST introduces microbial food as a strategy food production of the future
The global food crisis is increasing due to rapid population growth and declining food productivity to climate change. Moreover, today's food production and supply system emit a huge amount of carbon dioxide, reaching 30% of the total amount emitted by humanity, aggravating climate change. Sustainable and nutritious microbial food is attracting attention as a key to overcoming this impasse. KAIST (President Kwang Hyung Lee) announced on April 12th that Research Professor Kyeong Rok Choi of th
2024-04-12 -
research KAIST researchers developed a novel ultra-low power memory for neuromorphic computing
A team of Korean researchers is making headlines by developing a new memory device that can be used to replace existing memory or used in implementing neuromorphic computing for next-generation artificial intelligence hardware for its low processing costs and its ultra-low power consumption. KAIST (President Kwang-Hyung Lee) announced on April 4th that Professor Shinhyun Choi's research team in the School of Electrical Engineering has developed a next-generation phase change memory* device fe
2024-04-04 -
research A KAIST-SNUH Team Devises a Way to Make Mathematical Predictions to find Metabolites Related to Somatic Mutations in Cancers
Cancer is characterized by abnormal metabolic processes different from those of normal cells. Therefore, cancer metabolism has been extensively studied to develop effective diagnosis and treatment strategies. Notable achievements of cancer metabolism studies include the discovery of oncometabolites* and the approval of anticancer drugs by the U.S. Food and Drug Administration (FDA) that target enzymes associated with oncometabolites. Approved anticancer drugs such as ‘Tibsovo (active ingre
2024-03-18